Abstract
An expanding repertoire of “allosteric” drugs is revealing that structure-based drug design (SBDD) is not restricted to the “active site” of the target protein. Such compounds have been shown to bind distant regions of the protein topography, potentially providing higher levels of target specificity, reduced toxicity and access to new regions of chemical space. Unfortunately, the location of such allosteric pockets is not obvious in the absence of a bound crystal structure and the ability to predict their presence would be useful in the discovery of novel therapies. Here, we describe a method for the prediction of “druggable” binding sites that takes protein flexibility into account through the use of molecular dynamics (MD) simulation. By using a dynamic representation of the target, we are able to sample multiple protein conformations that may expose new drug-binding surfaces. We perform a fragment-based mapping analysis of individual structures in the MD ensemble using the FTMAP algorithm and then rank the most prolific probe-binding protein residues to determine potential “hot-spots” for further examination. This approach has recently been applied to a pair of human G-protein-coupled receptors (GPCRs), resulting in the detection of five potential allosteric sites.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hardy JA, Wells JA. Searching for new allosteric sites in enzymes. Curr Opin Struct Biol 2004; 14: 706–15.
Lewis JA, Lebois EP, Lindsley CW. Allosteric modulation of kinases and GPCRs: design principles and structural diversity. Curr Opin Chem Biol 2008; 12: 269–80.
Christopoulos A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 2002; 1: 198–210.
May LT, Leach K, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 2007; 47: 1–51.
Henrich S, Salo-Ahen OM, Huang B, Rippmann FF, Cruciani G, Wade RC. Computational approaches to identifying and characterizing protein binding sites for ligand design. J Mol Recognit 2009; 23: 209–19.
Perot S, Sperandio O, Miteva MA, Camproux AC, Villoutreix BO. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov Today 2010; 15: 656–67.
Brenke R, Kozakov D, Chuang GY, Beglov D, Hall D, Landon MR, Mattos C, Vajda S. Fragment-based identification of druggable ‘hot spots’ of proteins using Fourier domain correlation techniques. Bioinformatics 2009; 25: 621–7.
Landon MR, Lancia DR, Jr., Yu J, Thiel SC, Vajda S. Identification of hot spots within druggable binding regions by computational solvent mapping of proteins. J Med Chem 2007; 50: 1231–40.
Landon MR, Lieberman RL, Hoang QQ, Ju S, Caaveiro JM, Orwig SD, Kozakov D, Brenke R, Chuang GY, Beglov D, Vajda S, Petsko GA, Ringe D. Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase. J Comput Aided Mol Des 2009; 23: 491–500.
Carlson HA, McCammon JA. Accommodating protein flexibility in computational drug design. Mol Pharmacol 2000; 57: 213–8.
Teague SJ. Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2003; 2: 527–41.
Forman-Kay JD. The ‘dynamics’ in the thermodynamics of binding. Nat Struct Biol 1999; 6: 1086–7.
Verkhivker GM, Bouzida D, Gehlhaar DK, Rejto PA, Freer ST, Rose PW. Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective. Curr Opin Struct Biol 2002; 12: 197-203.
Cozzini P, Kellogg GE, Spyrakis F, Abraham DJ, Costantino G, Emerson A, Fanelli F, Gohlke H, Kuhn LA, Morris GM, Orozco M, Pertinhez TA, Rizzi M, Sotriffer CA. Target flexibility: an emerging consideration in drug discovery and design. J Med Chem 2008; 51: 6237–55.
Henzler AM, Rarey M. In Pursuit of Fully Flexible Protein-Ligand Docking: Modeling the Bilateral Mechanism of Binding. Molecular Informatics 2010; 29: 164–173.
Karplus M, McCammon JA. Molecular dynamics simulations of biomolecules. Nat Struct Biol 2002; 9: 646–52.
Amaro RE, Li WW. Emerging methods for ensemble-based virtual screening. Curr Top Med Chem 2010; 10: 3–13.
Ivetac A, McCammon JA. Mapping the druggable allosteric space of g-protein coupled receptors: a fragment-based molecular dynamics approach. Chem Biol Drug Des 2010; 76: 201–17.
Landon MR, Amaro RE, Baron R, Ngan CH, Ozonoff D, McCammon JA, Vajda S. Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. Chem Biol Drug Des 2008; 71: 106–16.
Hansson T, Oostenbrink C, van Gunsteren W. Molecular dynamics simulations. Curr Opin Struct Biol 2002; 12: 190–6.
Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem 2005; 26: 1701–18.
Scott WRP, Hunenberger PH, Tironi IG, Mark AE, Billeter SR, Fennen J, Torda AE, Huber T, Kruger P, van Gunsteren WF. The GROMOS biomolecular simulation program package. Journal of Physical Chemistry A 1999; 103: 3596–3607.
Caves LS, Evanseck JD, Karplus M. Locally accessible conformations of proteins: multiple molecular dynamics simulations of crambin. Protein Sci 1998; 7: 649–66.
Ivetac A, McCammon JA. Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations. J Mol Biol 2009; 388: 644–58.
Hamelberg D, Mongan J, McCammon JA. Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules. J Chem Phys 2004; 120: 11919–29.
Grubmüller H. Predicting slow structural transitions in macromolecular systems: Conformational flooding. Physical Review E 1995; 52: 2893.
Sugita Y, Okamoto Y. Replica-exchange molecular dynamics method for protein folding. Chemical Physics Letters 1999; 314: 141–151.
Acknowledgments
This work has been supported in part by the National Science Foundation (NSF), the National Institutes of Health (NIH), the Howard Hughes Medical Institute (HHMI), the National Biomedical Computation Resource (NBCR), the Center for Theoretical Biological Physics (CTBP), San Diego Supercomputer Center (SDSC), and the NSF Supercomputer Centers.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ivetac, A., McCammon, J.A. (2012). A Molecular Dynamics Ensemble-Based Approach for the Mapping of Druggable Binding Sites. In: Baron, R. (eds) Computational Drug Discovery and Design. Methods in Molecular Biology, vol 819. Springer, New York, NY. https://doi.org/10.1007/978-1-61779-465-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-61779-465-0_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-61779-464-3
Online ISBN: 978-1-61779-465-0
eBook Packages: Springer Protocols